Write For Us

Corona Crisis: DCGI approves phase II & III trial of Covaxin for kids

Sponsored Post Vitamin D2 Canada Persia
58 Views
Published
On May 12, the country's Drug Controller General of India (DCGI) has accepted the recommendation of the Subject Expert Committee and has approved the second and third clinical trials of the India Biotech's Corona Vaccine Covaxin. This clinical trial will be done in the age group of 2 to 18 years. Watch this news report to know more.
Category
Asia
Tags
Corona Crisis, Dcgi, covaxin approved in india
Sign in or sign up to post comments.
Be the first to comment